Overview

Eplerenone, ACE Inhibition and Albuminuria

Status:
Completed

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether eplerenone is more effective than doubling the dose of ACE inhibitor in reducing urinary protein (albumin) loss in diabetes mellitus

Phase:

Phase 2

Details

Lead Sponsor:

Radboud University

Treatments:

Eplerenone
Fosinopril
Spironolactone